nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—ATP1A1—Preimplantation Embryo—FOXQ1—breast cancer	0.019	0.134	CbGpPWpGaD
Bretylium—Edrophonium—ACHE—breast cancer	0.0186	0.63	CrCbGaD
Bretylium—Edrophonium—BCHE—breast cancer	0.011	0.37	CrCbGaD
Bretylium—ATP1A1—mammary gland—breast cancer	0.0103	0.113	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—DLX2—breast cancer	0.00929	0.0656	CbGpPWpGaD
Bretylium—ATP1A1—nipple—breast cancer	0.00849	0.0931	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—TBX3—breast cancer	0.00828	0.0585	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP7B—breast cancer	0.00729	0.0515	CbGpPWpGaD
Bretylium—ATP1A1—embryo—breast cancer	0.00701	0.0768	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—ESRRA—breast cancer	0.00662	0.0467	CbGpPWpGaD
Bretylium—ATP1A1—epithelium—breast cancer	0.00572	0.0627	CbGeAlD
Bretylium—ATP1A1—skin of body—breast cancer	0.00544	0.0596	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—DDIT3—breast cancer	0.00517	0.0365	CbGpPWpGaD
Bretylium—ATP1A1—endometrium—breast cancer	0.00513	0.0562	CbGeAlD
Bretylium—ATP1A1—uterus—breast cancer	0.00473	0.0518	CbGeAlD
Bretylium—ATP1A1—pituitary gland—breast cancer	0.00464	0.0509	CbGeAlD
Bretylium—ATP1A1—adipose tissue—breast cancer	0.00462	0.0507	CbGeAlD
Bretylium—ATP1A1—female reproductive system—breast cancer	0.00425	0.0466	CbGeAlD
Bretylium—ATP1A1—adrenal gland—breast cancer	0.00415	0.0454	CbGeAlD
Bretylium—ATP1A1—bone marrow—breast cancer	0.00401	0.044	CbGeAlD
Bretylium—ATP1A1—female gonad—breast cancer	0.00387	0.0424	CbGeAlD
Bretylium—SLC6A2—female reproductive system—breast cancer	0.00377	0.0414	CbGeAlD
Bretylium—SLC6A2—adrenal gland—breast cancer	0.00368	0.0404	CbGeAlD
Bretylium—ATP1A1—endocrine gland—breast cancer	0.0036	0.0394	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—GATA3—breast cancer	0.00323	0.0228	CbGpPWpGaD
Bretylium—SLC6A2—endocrine gland—breast cancer	0.00319	0.035	CbGeAlD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00287	0.0202	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—EGR1—breast cancer	0.00271	0.0192	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP7B—breast cancer	0.00252	0.0178	CbGpPWpGaD
Bretylium—ATP1A1—lymph node—breast cancer	0.00249	0.0272	CbGeAlD
Bretylium—SLC6A2—Monoamine Transport—ACHE—breast cancer	0.00245	0.0173	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00237	0.0168	CbGpPWpGaD
Bretylium—SLC6A2—lymph node—breast cancer	0.00221	0.0242	CbGeAlD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00217	0.0153	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00209	0.0148	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A10—breast cancer	0.00207	0.0146	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—ALDH3A1—breast cancer	0.00192	0.0136	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.0018	0.0127	CbGpPWpGaD
Bretylium—Hyperhidrosis—Tamoxifen—breast cancer	0.00179	0.00242	CcSEcCtD
Bretylium—Dizziness—Anastrozole—breast cancer	0.00179	0.00242	CcSEcCtD
Bretylium—Dizziness—Letrozole—breast cancer	0.00179	0.00242	CcSEcCtD
Bretylium—Confusional state—Goserelin—breast cancer	0.00178	0.00241	CcSEcCtD
Bretylium—Diarrhoea—Raloxifene—breast cancer	0.00175	0.00238	CcSEcCtD
Bretylium—Diarrhoea—Idarubicin—breast cancer	0.00175	0.00238	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—breast cancer	0.00175	0.00237	CcSEcCtD
Bretylium—Vertigo—Vinorelbine—breast cancer	0.00174	0.00236	CcSEcCtD
Bretylium—Shock—Goserelin—breast cancer	0.00174	0.00236	CcSEcCtD
Bretylium—Vomiting—Anastrozole—breast cancer	0.00172	0.00233	CcSEcCtD
Bretylium—Vomiting—Letrozole—breast cancer	0.00172	0.00233	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC39A7—breast cancer	0.00171	0.0121	CbGpPWpGaD
Bretylium—Feeling abnormal—Chlorambucil—breast cancer	0.00171	0.00232	CcSEcCtD
Bretylium—Hyperhidrosis—Goserelin—breast cancer	0.00171	0.00231	CcSEcCtD
Bretylium—Hiccups—Epirubicin—breast cancer	0.0017	0.00231	CcSEcCtD
Bretylium—Nausea—Ixabepilone—breast cancer	0.0017	0.00231	CcSEcCtD
Bretylium—Flushing—Irinotecan—breast cancer	0.0017	0.00231	CcSEcCtD
Bretylium—Gastrointestinal pain—Chlorambucil—breast cancer	0.0017	0.0023	CcSEcCtD
Bretylium—Dizziness—Raloxifene—breast cancer	0.0017	0.0023	CcSEcCtD
Bretylium—Mood swings—Capecitabine—breast cancer	0.00168	0.00228	CcSEcCtD
Bretylium—Orthostatic hypotension—Docetaxel—breast cancer	0.00168	0.00227	CcSEcCtD
Bretylium—Hypertension—Vinorelbine—breast cancer	0.00167	0.00227	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00167	0.0118	CbGpPWpGaD
Bretylium—Dyspnoea—Tamoxifen—breast cancer	0.00165	0.00223	CcSEcCtD
Bretylium—Abdominal pain—Chlorambucil—breast cancer	0.00164	0.00223	CcSEcCtD
Bretylium—Body temperature increased—Chlorambucil—breast cancer	0.00164	0.00223	CcSEcCtD
Bretylium—Vomiting—Raloxifene—breast cancer	0.00163	0.00221	CcSEcCtD
Bretylium—Vomiting—Idarubicin—breast cancer	0.00163	0.00221	CcSEcCtD
Bretylium—Orthostatic hypotension—Capecitabine—breast cancer	0.00162	0.0022	CcSEcCtD
Bretylium—Conjunctivitis—Paclitaxel—breast cancer	0.00162	0.0022	CcSEcCtD
Bretylium—Dyspnoea—Melphalan—breast cancer	0.00161	0.00219	CcSEcCtD
Bretylium—Nausea—Anastrozole—breast cancer	0.0016	0.00218	CcSEcCtD
Bretylium—Nausea—Letrozole—breast cancer	0.0016	0.00218	CcSEcCtD
Bretylium—Hypertension—Thiotepa—breast cancer	0.0016	0.00217	CcSEcCtD
Bretylium—Hiccups—Doxorubicin—breast cancer	0.00158	0.00214	CcSEcCtD
Bretylium—Dyspnoea—Goserelin—breast cancer	0.00157	0.00213	CcSEcCtD
Bretylium—Anxiety—Thiotepa—breast cancer	0.00157	0.00213	CcSEcCtD
Bretylium—Feeling abnormal—Vinblastine—breast cancer	0.00157	0.00213	CcSEcCtD
Bretylium—Gastrointestinal pain—Vinblastine—breast cancer	0.00156	0.00211	CcSEcCtD
Bretylium—Angina pectoris—Docetaxel—breast cancer	0.00154	0.00209	CcSEcCtD
Bretylium—ATP1A1—Preimplantation Embryo—CDH1—breast cancer	0.00153	0.0108	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00153	0.0108	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00153	0.0108	CbGpPWpGaD
Bretylium—Bradycardia—Paclitaxel—breast cancer	0.00152	0.00207	CcSEcCtD
Bretylium—Nausea—Raloxifene—breast cancer	0.00152	0.00206	CcSEcCtD
Bretylium—Nausea—Idarubicin—breast cancer	0.00152	0.00206	CcSEcCtD
Bretylium—Confusional state—Thiotepa—breast cancer	0.00152	0.00206	CcSEcCtD
Bretylium—Gastrointestinal pain—Tamoxifen—breast cancer	0.00151	0.00205	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC2A5—breast cancer	0.00151	0.0106	CbGpPWpGaD
Bretylium—Abdominal pain—Vinblastine—breast cancer	0.0015	0.00204	CcSEcCtD
Bretylium—Sweating increased—Capecitabine—breast cancer	0.0015	0.00203	CcSEcCtD
Bretylium—Angina pectoris—Capecitabine—breast cancer	0.0015	0.00203	CcSEcCtD
Bretylium—Abdominal pain—Tamoxifen—breast cancer	0.00146	0.00198	CcSEcCtD
Bretylium—Feeling abnormal—Goserelin—breast cancer	0.00145	0.00197	CcSEcCtD
Bretylium—Gastrointestinal pain—Goserelin—breast cancer	0.00144	0.00196	CcSEcCtD
Bretylium—Vertigo—Irinotecan—breast cancer	0.00144	0.00195	CcSEcCtD
Bretylium—Syncope—Irinotecan—breast cancer	0.00143	0.00194	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00142	0.01	CbGpPWpGaD
Bretylium—Diarrhoea—Chlorambucil—breast cancer	0.00142	0.00193	CcSEcCtD
Bretylium—Dyspnoea—Vinorelbine—breast cancer	0.00141	0.00191	CcSEcCtD
Bretylium—Loss of consciousness—Irinotecan—breast cancer	0.0014	0.0019	CcSEcCtD
Bretylium—Abdominal pain—Goserelin—breast cancer	0.0014	0.00189	CcSEcCtD
Bretylium—Body temperature increased—Goserelin—breast cancer	0.0014	0.00189	CcSEcCtD
Bretylium—Flushing—Paclitaxel—breast cancer	0.00139	0.00188	CcSEcCtD
Bretylium—Hypertension—Mitoxantrone—breast cancer	0.00138	0.00187	CcSEcCtD
Bretylium—Hypertension—Irinotecan—breast cancer	0.00138	0.00187	CcSEcCtD
Bretylium—Conjunctivitis—Docetaxel—breast cancer	0.00137	0.00186	CcSEcCtD
Bretylium—Anxiety—Mitoxantrone—breast cancer	0.00136	0.00184	CcSEcCtD
Bretylium—Lethargy—Methotrexate—breast cancer	0.00135	0.00183	CcSEcCtD
Bretylium—Hypertension—Gemcitabine—breast cancer	0.00134	0.00182	CcSEcCtD
Bretylium—Conjunctivitis—Capecitabine—breast cancer	0.00133	0.0018	CcSEcCtD
Bretylium—Vomiting—Chlorambucil—breast cancer	0.00132	0.00179	CcSEcCtD
Bretylium—Confusional state—Irinotecan—breast cancer	0.00132	0.00178	CcSEcCtD
Bretylium—Confusional state—Mitoxantrone—breast cancer	0.00132	0.00178	CcSEcCtD
Bretylium—Feeling abnormal—Vinorelbine—breast cancer	0.0013	0.00177	CcSEcCtD
Bretylium—Diarrhoea—Vinblastine—breast cancer	0.0013	0.00177	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.0013	0.00919	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.0013	0.00919	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC39A6—breast cancer	0.0013	0.00916	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Vinorelbine—breast cancer	0.00129	0.00175	CcSEcCtD
Bretylium—Shock—Irinotecan—breast cancer	0.00128	0.00174	CcSEcCtD
Bretylium—Shock—Mitoxantrone—breast cancer	0.00128	0.00174	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00127	0.00895	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—COX11—breast cancer	0.00127	0.00895	CbGpPWpGaD
Bretylium—Diarrhoea—Tamoxifen—breast cancer	0.00126	0.00172	CcSEcCtD
Bretylium—Lethargy—Epirubicin—breast cancer	0.00126	0.00171	CcSEcCtD
Bretylium—Hyperhidrosis—Mitoxantrone—breast cancer	0.00126	0.00171	CcSEcCtD
Bretylium—Hyperhidrosis—Irinotecan—breast cancer	0.00126	0.00171	CcSEcCtD
Bretylium—Confusional state—Fluorouracil—breast cancer	0.00126	0.00171	CcSEcCtD
Bretylium—Dizziness—Vinblastine—breast cancer	0.00126	0.00171	CcSEcCtD
Bretylium—Mood swings—Methotrexate—breast cancer	0.00125	0.0017	CcSEcCtD
Bretylium—Bradycardia—Capecitabine—breast cancer	0.00125	0.0017	CcSEcCtD
Bretylium—Body temperature increased—Vinorelbine—breast cancer	0.00125	0.0017	CcSEcCtD
Bretylium—Abdominal pain—Vinorelbine—breast cancer	0.00125	0.0017	CcSEcCtD
Bretylium—Feeling abnormal—Thiotepa—breast cancer	0.00124	0.00169	CcSEcCtD
Bretylium—Diarrhoea—Melphalan—breast cancer	0.00124	0.00168	CcSEcCtD
Bretylium—Gastrointestinal pain—Thiotepa—breast cancer	0.00123	0.00167	CcSEcCtD
Bretylium—Nausea—Chlorambucil—breast cancer	0.00123	0.00167	CcSEcCtD
Bretylium—Hyperhidrosis—Gemcitabine—breast cancer	0.00123	0.00167	CcSEcCtD
Bretylium—Dizziness—Tamoxifen—breast cancer	0.00122	0.00166	CcSEcCtD
Bretylium—Affect lability—Epirubicin—breast cancer	0.00122	0.00165	CcSEcCtD
Bretylium—Vomiting—Vinblastine—breast cancer	0.00121	0.00164	CcSEcCtD
Bretylium—Diarrhoea—Goserelin—breast cancer	0.00121	0.00164	CcSEcCtD
Bretylium—Abdominal pain—Thiotepa—breast cancer	0.00119	0.00162	CcSEcCtD
Bretylium—Body temperature increased—Thiotepa—breast cancer	0.00119	0.00162	CcSEcCtD
Bretylium—Flushing—Docetaxel—breast cancer	0.00118	0.0016	CcSEcCtD
Bretylium—Vomiting—Tamoxifen—breast cancer	0.00118	0.00159	CcSEcCtD
Bretylium—Mood swings—Epirubicin—breast cancer	0.00117	0.00159	CcSEcCtD
Bretylium—Vertigo—Paclitaxel—breast cancer	0.00117	0.00159	CcSEcCtD
Bretylium—Syncope—Paclitaxel—breast cancer	0.00117	0.00158	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—breast cancer	0.00117	0.00158	CcSEcCtD
Bretylium—Dizziness—Goserelin—breast cancer	0.00117	0.00158	CcSEcCtD
Bretylium—Dyspnoea—Irinotecan—breast cancer	0.00116	0.00158	CcSEcCtD
Bretylium—Dyspnoea—Mitoxantrone—breast cancer	0.00116	0.00158	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.00116	0.00818	CbGpPWpGaD
Bretylium—Vomiting—Melphalan—breast cancer	0.00115	0.00156	CcSEcCtD
Bretylium—Loss of consciousness—Paclitaxel—breast cancer	0.00115	0.00155	CcSEcCtD
Bretylium—Flushing—Capecitabine—breast cancer	0.00114	0.00155	CcSEcCtD
Bretylium—Dyspnoea—Gemcitabine—breast cancer	0.00113	0.00154	CcSEcCtD
Bretylium—Nausea—Vinblastine—breast cancer	0.00113	0.00153	CcSEcCtD
Bretylium—Orthostatic hypotension—Epirubicin—breast cancer	0.00113	0.00153	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—breast cancer	0.00113	0.00153	CcSEcCtD
Bretylium—Hypertension—Paclitaxel—breast cancer	0.00113	0.00153	CcSEcCtD
Bretylium—Vomiting—Goserelin—breast cancer	0.00112	0.00152	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00112	0.00788	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00112	0.00788	CbGpPWpGaD
Bretylium—Dyspnoea—Fluorouracil—breast cancer	0.00111	0.00151	CcSEcCtD
Bretylium—Anxiety—Paclitaxel—breast cancer	0.00111	0.0015	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GSTA3—breast cancer	0.0011	0.00779	CbGpPWpGaD
Bretylium—Nausea—Tamoxifen—breast cancer	0.0011	0.00149	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—breast cancer	0.00108	0.00147	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.00108	0.00764	CbGpPWpGaD
Bretylium—Diarrhoea—Vinorelbine—breast cancer	0.00108	0.00147	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.00108	0.00762	CbGpPWpGaD
Bretylium—Nausea—Melphalan—breast cancer	0.00108	0.00146	CcSEcCtD
Bretylium—Feeling abnormal—Mitoxantrone—breast cancer	0.00107	0.00146	CcSEcCtD
Bretylium—Feeling abnormal—Irinotecan—breast cancer	0.00107	0.00146	CcSEcCtD
Bretylium—Confusional state—Paclitaxel—breast cancer	0.00107	0.00145	CcSEcCtD
Bretylium—Gastrointestinal pain—Irinotecan—breast cancer	0.00107	0.00145	CcSEcCtD
Bretylium—Gastrointestinal pain—Mitoxantrone—breast cancer	0.00107	0.00145	CcSEcCtD
Bretylium—Nausea—Goserelin—breast cancer	0.00105	0.00142	CcSEcCtD
Bretylium—Feeling abnormal—Gemcitabine—breast cancer	0.00105	0.00142	CcSEcCtD
Bretylium—Shock—Paclitaxel—breast cancer	0.00105	0.00142	CcSEcCtD
Bretylium—Dizziness—Vinorelbine—breast cancer	0.00105	0.00142	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—breast cancer	0.00105	0.00142	CcSEcCtD
Bretylium—Angina pectoris—Epirubicin—breast cancer	0.00104	0.00141	CcSEcCtD
Bretylium—Diarrhoea—Thiotepa—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Body temperature increased—Irinotecan—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Abdominal pain—Irinotecan—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Body temperature increased—Mitoxantrone—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Abdominal pain—Mitoxantrone—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Feeling abnormal—Fluorouracil—breast cancer	0.00103	0.0014	CcSEcCtD
Bretylium—Hyperhidrosis—Paclitaxel—breast cancer	0.00103	0.00139	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GSTA4—breast cancer	0.00101	0.00712	CbGpPWpGaD
Bretylium—Vomiting—Vinorelbine—breast cancer	0.00101	0.00136	CcSEcCtD
Bretylium—Body temperature increased—Gemcitabine—breast cancer	0.001	0.00136	CcSEcCtD
Bretylium—Dizziness—Thiotepa—breast cancer	0.000999	0.00135	CcSEcCtD
Bretylium—Syncope—Docetaxel—breast cancer	0.000991	0.00134	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—breast cancer	0.00099	0.00134	CcSEcCtD
Bretylium—Body temperature increased—Fluorouracil—breast cancer	0.000987	0.00134	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000987	0.00697	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GPX2—breast cancer	0.000983	0.00694	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTA2—breast cancer	0.000983	0.00694	CbGpPWpGaD
Bretylium—Loss of consciousness—Docetaxel—breast cancer	0.000971	0.00132	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—breast cancer	0.000964	0.00131	CcSEcCtD
Bretylium—Vertigo—Capecitabine—breast cancer	0.000961	0.0013	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.00096	0.00678	CbGpPWpGaD
Bretylium—Vomiting—Thiotepa—breast cancer	0.00096	0.0013	CcSEcCtD
Bretylium—Syncope—Capecitabine—breast cancer	0.000959	0.0013	CcSEcCtD
Bretylium—Hypertension—Docetaxel—breast cancer	0.000954	0.00129	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.00095	0.0067	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.00095	0.0067	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTA1—breast cancer	0.000949	0.0067	CbGpPWpGaD
Bretylium—Dyspnoea—Paclitaxel—breast cancer	0.000948	0.00129	CcSEcCtD
Bretylium—Loss of consciousness—Capecitabine—breast cancer	0.00094	0.00127	CcSEcCtD
Bretylium—Nausea—Vinorelbine—breast cancer	0.000939	0.00127	CcSEcCtD
Bretylium—Conjunctivitis—Epirubicin—breast cancer	0.000927	0.00126	CcSEcCtD
Bretylium—Hypertension—Capecitabine—breast cancer	0.000923	0.00125	CcSEcCtD
Bretylium—Confusional state—Docetaxel—breast cancer	0.000909	0.00123	CcSEcCtD
Bretylium—Anxiety—Capecitabine—breast cancer	0.000907	0.00123	CcSEcCtD
Bretylium—Nausea—Thiotepa—breast cancer	0.000897	0.00122	CcSEcCtD
Bretylium—Diarrhoea—Irinotecan—breast cancer	0.000892	0.00121	CcSEcCtD
Bretylium—Diarrhoea—Mitoxantrone—breast cancer	0.000892	0.00121	CcSEcCtD
Bretylium—Shock—Docetaxel—breast cancer	0.000887	0.0012	CcSEcCtD
Bretylium—Confusional state—Capecitabine—breast cancer	0.00088	0.00119	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000878	0.0062	CbGpPWpGaD
Bretylium—Feeling abnormal—Paclitaxel—breast cancer	0.000877	0.00119	CcSEcCtD
Bretylium—Bradycardia—Epirubicin—breast cancer	0.000871	0.00118	CcSEcCtD
Bretylium—Gastrointestinal pain—Paclitaxel—breast cancer	0.00087	0.00118	CcSEcCtD
Bretylium—Diarrhoea—Gemcitabine—breast cancer	0.000869	0.00118	CcSEcCtD
Bretylium—Dizziness—Irinotecan—breast cancer	0.000862	0.00117	CcSEcCtD
Bretylium—Shock—Capecitabine—breast cancer	0.000859	0.00116	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—breast cancer	0.000858	0.00116	CcSEcCtD
Bretylium—Diarrhoea—Fluorouracil—breast cancer	0.000855	0.00116	CcSEcCtD
Bretylium—Hyperhidrosis—Capecitabine—breast cancer	0.000844	0.00114	CcSEcCtD
Bretylium—Body temperature increased—Paclitaxel—breast cancer	0.000841	0.00114	CcSEcCtD
Bretylium—Abdominal pain—Paclitaxel—breast cancer	0.000841	0.00114	CcSEcCtD
Bretylium—Vomiting—Mitoxantrone—breast cancer	0.000829	0.00112	CcSEcCtD
Bretylium—Vomiting—Irinotecan—breast cancer	0.000829	0.00112	CcSEcCtD
Bretylium—Dizziness—Fluorouracil—breast cancer	0.000826	0.00112	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—IL1B—breast cancer	0.000818	0.00578	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000818	0.00577	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000817	0.00576	CbGpPWpGaD
Bretylium—Vomiting—Gemcitabine—breast cancer	0.000808	0.0011	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—breast cancer	0.000806	0.00109	CcSEcCtD
Bretylium—Dyspnoea—Docetaxel—breast cancer	0.000804	0.00109	CcSEcCtD
Bretylium—Flushing—Epirubicin—breast cancer	0.000794	0.00108	CcSEcCtD
Bretylium—Vomiting—Fluorouracil—breast cancer	0.000794	0.00108	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC2A2—breast cancer	0.00078	0.00551	CbGpPWpGaD
Bretylium—Dyspnoea—Capecitabine—breast cancer	0.000778	0.00106	CcSEcCtD
Bretylium—Nausea—Irinotecan—breast cancer	0.000775	0.00105	CcSEcCtD
Bretylium—Nausea—Mitoxantrone—breast cancer	0.000775	0.00105	CcSEcCtD
Bretylium—Nausea—Gemcitabine—breast cancer	0.000755	0.00102	CcSEcCtD
Bretylium—Feeling abnormal—Docetaxel—breast cancer	0.000743	0.00101	CcSEcCtD
Bretylium—Nausea—Fluorouracil—breast cancer	0.000742	0.00101	CcSEcCtD
Bretylium—Gastrointestinal pain—Docetaxel—breast cancer	0.000737	0.001	CcSEcCtD
Bretylium—Flushing—Doxorubicin—breast cancer	0.000735	0.000997	CcSEcCtD
Bretylium—Diarrhoea—Paclitaxel—breast cancer	0.000728	0.000987	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000723	0.00511	CbGpPWpGaD
Bretylium—Feeling abnormal—Capecitabine—breast cancer	0.000719	0.000975	CcSEcCtD
Bretylium—Vertigo—Methotrexate—breast cancer	0.000715	0.00097	CcSEcCtD
Bretylium—Gastrointestinal pain—Capecitabine—breast cancer	0.000714	0.000968	CcSEcCtD
Bretylium—Abdominal pain—Docetaxel—breast cancer	0.000713	0.000966	CcSEcCtD
Bretylium—Body temperature increased—Docetaxel—breast cancer	0.000713	0.000966	CcSEcCtD
Bretylium—Dizziness—Paclitaxel—breast cancer	0.000703	0.000954	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000694	0.0049	CbGpPWpGaD
Bretylium—Body temperature increased—Capecitabine—breast cancer	0.00069	0.000936	CcSEcCtD
Bretylium—Abdominal pain—Capecitabine—breast cancer	0.00069	0.000936	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—TGFB2—breast cancer	0.000681	0.00481	CbGpPWpGaD
Bretylium—Vomiting—Paclitaxel—breast cancer	0.000676	0.000917	CcSEcCtD
Bretylium—Vertigo—Epirubicin—breast cancer	0.000669	0.000908	CcSEcCtD
Bretylium—Syncope—Epirubicin—breast cancer	0.000668	0.000906	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000662	0.00467	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000662	0.00467	CbGpPWpGaD
Bretylium—Confusional state—Methotrexate—breast cancer	0.000655	0.000888	CcSEcCtD
Bretylium—Loss of consciousness—Epirubicin—breast cancer	0.000655	0.000888	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SQSTM1—breast cancer	0.000644	0.00455	CbGpPWpGaD
Bretylium—Hypertension—Epirubicin—breast cancer	0.000643	0.000872	CcSEcCtD
Bretylium—Anxiety—Epirubicin—breast cancer	0.000632	0.000857	CcSEcCtD
Bretylium—Nausea—Paclitaxel—breast cancer	0.000632	0.000857	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—breast cancer	0.000628	0.000852	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC5A5—breast cancer	0.000626	0.00442	CbGpPWpGaD
Bretylium—Vertigo—Doxorubicin—breast cancer	0.000619	0.00084	CcSEcCtD
Bretylium—Syncope—Doxorubicin—breast cancer	0.000618	0.000838	CcSEcCtD
Bretylium—Diarrhoea—Docetaxel—breast cancer	0.000617	0.000836	CcSEcCtD
Bretylium—Confusional state—Epirubicin—breast cancer	0.000613	0.000831	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—breast cancer	0.000606	0.000822	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—NQO1—breast cancer	0.000604	0.00427	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A1—breast cancer	0.000604	0.00427	CbGpPWpGaD
Bretylium—Shock—Epirubicin—breast cancer	0.000598	0.000811	CcSEcCtD
Bretylium—Diarrhoea—Capecitabine—breast cancer	0.000597	0.00081	CcSEcCtD
Bretylium—Dizziness—Docetaxel—breast cancer	0.000596	0.000808	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—breast cancer	0.000595	0.000807	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—TNF—breast cancer	0.000594	0.00419	CbGpPWpGaD
Bretylium—Hyperhidrosis—Epirubicin—breast cancer	0.000588	0.000797	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—breast cancer	0.000585	0.000793	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—breast cancer	0.000579	0.000786	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000578	0.00408	CbGpPWpGaD
Bretylium—Dizziness—Capecitabine—breast cancer	0.000577	0.000783	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—RAF1—breast cancer	0.000574	0.00405	CbGpPWpGaD
Bretylium—Vomiting—Docetaxel—breast cancer	0.000573	0.000777	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HSP90AA1—breast cancer	0.000568	0.00401	CbGpPWpGaD
Bretylium—Confusional state—Doxorubicin—breast cancer	0.000567	0.000769	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000566	0.004	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—EGR1—breast cancer	0.000561	0.00396	CbGpPWpGaD
Bretylium—Vomiting—Capecitabine—breast cancer	0.000555	0.000753	CcSEcCtD
Bretylium—Shock—Doxorubicin—breast cancer	0.000554	0.000751	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000548	0.00387	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000548	0.00387	CbGpPWpGaD
Bretylium—Hyperhidrosis—Doxorubicin—breast cancer	0.000544	0.000738	CcSEcCtD
Bretylium—Dyspnoea—Epirubicin—breast cancer	0.000542	0.000735	CcSEcCtD
Bretylium—Nausea—Docetaxel—breast cancer	0.000536	0.000726	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—breast cancer	0.000535	0.000726	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—breast cancer	0.000531	0.00072	CcSEcCtD
Bretylium—Nausea—Capecitabine—breast cancer	0.000518	0.000703	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—breast cancer	0.000514	0.000697	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—breast cancer	0.000514	0.000697	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000505	0.00356	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTP1—breast cancer	0.000504	0.00356	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFBR2—breast cancer	0.000504	0.00356	CbGpPWpGaD
Bretylium—Dyspnoea—Doxorubicin—breast cancer	0.000502	0.00068	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000501	0.00354	CbGpPWpGaD
Bretylium—Feeling abnormal—Epirubicin—breast cancer	0.000501	0.000679	CcSEcCtD
Bretylium—Gastrointestinal pain—Epirubicin—breast cancer	0.000497	0.000674	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HMOX1—breast cancer	0.000497	0.00351	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000492	0.00347	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000486	0.00343	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000483	0.00341	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000483	0.00341	CbGpPWpGaD
Bretylium—Body temperature increased—Epirubicin—breast cancer	0.000481	0.000652	CcSEcCtD
Bretylium—Abdominal pain—Epirubicin—breast cancer	0.000481	0.000652	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—breast cancer	0.000464	0.000629	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000463	0.00327	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTM1—breast cancer	0.000463	0.00327	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HGF—breast cancer	0.000463	0.00327	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Doxorubicin—breast cancer	0.00046	0.000624	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—NRG1—breast cancer	0.000455	0.00321	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000447	0.00316	CbGpPWpGaD
Bretylium—Abdominal pain—Doxorubicin—breast cancer	0.000445	0.000603	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—breast cancer	0.000445	0.000603	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—breast cancer	0.000445	0.000603	CcSEcCtD
Bretylium—Dizziness—Methotrexate—breast cancer	0.00043	0.000583	CcSEcCtD
Bretylium—Diarrhoea—Epirubicin—breast cancer	0.000416	0.000564	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000415	0.00293	CbGpPWpGaD
Bretylium—Vomiting—Methotrexate—breast cancer	0.000413	0.00056	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000409	0.00289	CbGpPWpGaD
Bretylium—Dizziness—Epirubicin—breast cancer	0.000402	0.000545	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000399	0.00282	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000394	0.00278	CbGpPWpGaD
Bretylium—Vomiting—Epirubicin—breast cancer	0.000387	0.000524	CcSEcCtD
Bretylium—Nausea—Methotrexate—breast cancer	0.000386	0.000523	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—breast cancer	0.000385	0.000522	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000381	0.00269	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.00038	0.00268	CbGpPWpGaD
Bretylium—Dizziness—Doxorubicin—breast cancer	0.000372	0.000505	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000368	0.0026	CbGpPWpGaD
Bretylium—Nausea—Epirubicin—breast cancer	0.000361	0.00049	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—breast cancer	0.000358	0.000485	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000353	0.00249	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000353	0.00249	CbGpPWpGaD
Bretylium—Nausea—Doxorubicin—breast cancer	0.000334	0.000453	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.0003	0.00212	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.00025	0.00176	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000245	0.00173	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—breast cancer	0.000221	0.00156	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000218	0.00154	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00021	0.00148	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.0002	0.00141	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—RAF1—breast cancer	0.0002	0.00141	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000194	0.00137	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFB1—breast cancer	0.000189	0.00133	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000188	0.00133	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000177	0.00125	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000173	0.00122	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000159	0.00112	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000153	0.00108	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—breast cancer	9.56e-05	0.000675	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—RAF1—breast cancer	8.65e-05	0.00061	CbGpPWpGaD
